Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Obel

Showing results (181-190 of 288) with videos related to

Pageof 29
Sort By:
Scandinavian Journal of Infectious Diseases|July 19, 2012
Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: a nationwide cohort studyKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Infectious Diseases (London, England)|October 14, 2022
Invasive procedures and risk of brain abscess: a nationwide, population-based case-control studyLars Haukali Omland, Jacob Bodilsen, Jannik Helweg-Larsen, et al.
Frontiers in Immunology|October 10, 2022
Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort studyTerese L Katzenstein, Line D Rasmussen, Camilla Helberg Drabe, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 17, 2016
Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral loadLise Wegner Thørner, Christian Erikstrup, Lene Holm Harritshøj, et al.
The Journal of Infectious Diseases|November 15, 2008
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort studyFrederik Neess Engsig, Ann-Brit Eg Hansen, Lars Haukali Omland, et al.
AIDS (London, England)|May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma developmentMaja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2006
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort studyNina Weis, Bjarne O Lindhardt, Gitte Kronborg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug usersZitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
Journal of the International AIDS Society|November 14, 2014
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Pageof 29

Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Scandinavian Journal of Infectious Diseases|July 19, 2012
Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: a nationwide cohort studyKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Infectious Diseases (London, England)|October 14, 2022
Invasive procedures and risk of brain abscess: a nationwide, population-based case-control studyLars Haukali Omland, Jacob Bodilsen, Jannik Helweg-Larsen, et al.
Frontiers in Immunology|October 10, 2022
Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort studyTerese L Katzenstein, Line D Rasmussen, Camilla Helberg Drabe, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 17, 2016
Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral loadLise Wegner Thørner, Christian Erikstrup, Lene Holm Harritshøj, et al.
The Journal of Infectious Diseases|November 15, 2008
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort studyFrederik Neess Engsig, Ann-Brit Eg Hansen, Lars Haukali Omland, et al.
AIDS (London, England)|May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma developmentMaja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2006
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort studyNina Weis, Bjarne O Lindhardt, Gitte Kronborg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug usersZitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
Journal of the International AIDS Society|November 14, 2014
Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Pageof 29